![](/img/cover-not-exists.png)
P-490 A chinese, multicenter, phase II trial of gefitinib (IRESSA) inpatients with non-small cell lung cancer who had failed previous chemotherapy
Guan, Z., Zhang, L., Li, L., Jiang, G., Liu, X., Chu, D., Li, W.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80983-3
Date:
July, 2005
File:
PDF, 140 KB
english, 2005